Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M pro inhibitors

被引：0
|
作者：
Peng, Jin-Qi [1 ]
Xiao, Ya-Qi [1 ]
Long, Jiao [1 ]
Zhang, Shuang-Shuang [1 ]
Zhu, Yuan-Yuan [2 ]
Gu, Shuang-Xi [1 ]
机构：
[1] Wuhan Inst Technol, Sch Chem Engn & Pharm, Hubei Key Lab Novel Reactor & Green Chem Technol, Wuhan 430205, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430205, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2024年 / 114卷
关键词：
SARS-CoV-2; Main protease; Dithiocarbamates derivatives; Drug design;
D O I：
10.1016/j.bmcl.2024.130011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
SARS-CoV-2 continues to mutate, spread, and impact public health and daily life. The main protease (Mpro) is essential for the replication and maturation of SARS-CoV-2, making it an ideal target for anti-coronaviral drug discovery and development due to its high conservation and lack of homologous proteases in humans. Herein, we designed and synthesized a series of dithiocarbamate derivatives as potent SARS-CoV-2 M pro inhibitors. Notably, compound L2 exhibited an IC50 value of 9.1 +/- 2.0 nM against SARS-CoV-2 M pro , underscoring its potential as a promising candidate for anti-coronaviral therapy and justifying further research and development.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
    Qiao, Jingxin
    Li, Yue-Shan
    Zeng, Rui
    Liu, Feng-Liang
    Luo, Rong-Hua
    Huang, Chong
    Wang, Yi-Fei
    Zhang, Jie
    Quan, Baoxue
    Shen, Chenjian
    Mao, Xin
    Liu, Xinlei
    Sun, Weining
    Yang, Wei
    Ni, Xincheng
    Wang, Kai
    Xu, Ling
    Duan, Zi-Lei
    Zou, Qing-Cui
    Zhang, Hai-Lin
    Qu, Wang
    Long, Yang-Hao-Peng
    Li, Ming-Hua
    Yang, Rui-Cheng
    Liu, Xiaolong
    You, Jing
    Zhou, Yangli
    Yao, Rui
    Li, Wen-Pei
    Liu, Jing-Ming
    Chen, Pei
    Liu, Yang
    Lin, Gui-Feng
    Yang, Xin
    Zou, Jun
    Li, Linli
    Hu, Yiguo
    Lu, Guang-Wen
    Li, Wei-Min
    Wei, Yu-Quan
    Zheng, Yong-Tang
    Lei, Jian
    Yang, Shengyong
    SCIENCE, 2021, 371 (6536) : 1374 - +
  • [22] Design, synthesis and activity evaluation of 4-(quinoline-2-yl)aniline derivatives as SARS-CoV-2 main protease inhibitors
    Bao, Honglei
    Meng, Hui
    Gong, Shilin
    Gong, Yaguo
    Tu, Gao
    Du, Zhenya
    Wang, Yuwei
    Wu, Jianlin
    Ma, Chunhua
    Ma, Qinhai
    Yao, Xiaojun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 121
  • [23] Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
    Fassi, Enrico M. A.
    Manenti, Marco
    Citarella, Andrea
    Dei Cas, Michele
    Casati, Sara
    Micale, Nicola
    Schirmeister, Tanja
    Roda, Gabriella
    Silvani, Alessandra
    Grazioso, Giovanni
    MOLECULES, 2023, 28 (05):
  • [24] Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors
    Stille, Julia K. K.
    Tjutrins, Jevgenijs
    Wang, Guanyu
    Venegas, Felipe A. A.
    Hennecker, Christopher
    Rueda, Andres M.
    Sharon, Itai
    Blaine, Nicole
    Miron, Caitlin E.
    Pinus, Sharon
    Labarre, Anne
    Plescia, Jessica
    Patrascu, Mihai Burai
    Zhang, Xiaocong
    Wahba, Alexander S.
    Vlaho, Danielle
    Huot, Mitchell J.
    Schmeing, T. Martin
    Mittermaier, Anthony K. K.
    Moitessier, Nicolas
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [25] Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2
    Yan, Yong
    Liu, Hanwen
    Wu, Di
    Gu, Zhihao
    Guo, Wenhao
    Yao, Hequan
    Lin, Kejiang
    Li, Xuanyi
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (09) : 887 - 903
  • [26] Synthetic Coumarin Derivatives as SARS-CoV-2 Major Protease Inhibitors: Design, Synthesis, Bioevaluation and Molecular Docking
    Mohamed, Nada M.
    Eltelbany, Rania F. A.
    CHEMISTRYSELECT, 2021, 6 (47): : 13616 - 13626
  • [27] Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2
    Singh, Vishal K.
    Chaurasia, Himani
    Kumari, Priyanka
    Som, Anup
    Mishra, Richa
    Srivastava, Ritika
    Naaz, Farha
    Singh, Anuradha
    Singh, Ramendra K.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21): : 10519 - 10542
  • [28] Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2
    Juang, Yu-Pu
    Chou, Yu-Ting
    Lin, Ru-Xian
    Ma, Hsiu-Hua
    Chao, Tai-Ling
    Jan, Jia-Tsrong
    Chang, Sui-Yuan
    Liang, Pi-Hui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235
  • [29] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
    Katagishi, Daiki
    Yasuda, Daisuke
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    Ohe, Tomoyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [30] Design, synthesis and biological evaluation of 2-aminoquinazolin-4 (3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments
    Lee, Jun Young
    Shin, Young Sup
    Jeon, Sangeun
    Lee, Se In
    Noh, Soojin
    Cho, Jung-Eun
    Jang, Min Seong
    Kim, Seungtaek
    Song, Jong Hwan
    Kim, Hyoung Rae
    Park, Chul Min
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 39
12345